Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 89093 · Class II · Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Key facts
| Event ID | 89093 |
|---|---|
| Recall numbers | B-0073-2022 |
| Recalling firm | Rhode Island Blood Center, A Division of New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis products, for which quality control for residual white blood cell count testing was not performed, were distributed. |
| Initiation date | Oct 19, 2021 |
| Report date | Dec 22, 2021 |
| Termination date | Dec 10, 2021 |
| City | Providence |
| State | RI |
| Country | United States |
| FEI number | 1270007 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: